Douglas K. Rex MDDistinguished Professor of Medicine, Indiana University School of Medicine, Chancellor’s Professor, Indiana University Purdue University Indianapolis, and Director of Endoscopy, Indiana University Hospital, Indianapolis, Indiana
Dr. Douglas K. Rex is Distinguished Professor of Medicine at Indiana University School of Medicine, Chancellor’s Professor at Indiana University Purdue University Indianapolis, and Director of Endoscopy at Indiana University Hospital in Indianapolis. He graduated from Harvard College, Summa Cum Laude in 1976 and with highest distinction from Indiana University School of Medicine in 1980. He served as Chief Medical Resident at Indiana University Hospital and joined the faculty at Indiana University in 1985. He received the Outstanding Teacher Award in the Introduction to Medicine course five times and has been awarded the Indiana University School of Medicine Outstanding Teacher Award as well as Department of Medicine’s Excellence in Teaching Award. He is a full-time clinical gastroenterologist at Indiana University Hospital. His major research interests have been in colorectal disease and, in particular, colorectal cancer screening and the technical performance of colonoscopy. He co-authored the colorectal cancer screening recommendations of the American College of Gastroenterology and the U.S. Multi-Society Task Force on Colorectal Cancer. He also authored the recommendations on quality in colonoscopy of the U.S. Multi-Society Task Force on Colorectal Cancer and the American College of Gastroenterology/American Society of Gastrointestinal Endoscopy. He has authored more than 190 original research papers, 55 book chapters, 180 invited papers, 40 editorials, and 40 guideline papers. He is an Associate Editor of Journal Watch Gastroenterology and GI and Hepatology News, and a member of the Editorial Boards of Gastroenterology, The Journal of Clinical Gastroenterology, Techniques in Gastrointestinal Endoscopy, Gastroenterology & Hepatology, Expert Review of Gastroenterology and Hepatology, Medscape Gastroenterology, World Journal of Gastrointestinal Pharmacology and Therapeutics (WJGPT), Annals of Gastroenterology & Hepatology, World Journal of Gastrointestinal Oncology, Comparative Effectiveness Research, Journal of Anesthesia & Clinical Research, and the World Journal of Gastrointestinal Pathophysiology. He is the current chair of the U.S. Multi-Society (ACG, ASGE, AGA, ACP-ASIM) Task Force on Colorectal Cancer. He has also served in the American College of Gastroenterology as Chairman of the Board of Governors and is a Past President of the ACG.
DisclosuresDr. Rex discloses the following:
Consultant: Olympus Corporation, Boston Scientific, Medtronic, Aries Pharmaceutical, Braintree Laboratories
Research Support: EndoAid, Olympus Corporation, Medivators, Erbe USA Inc.
Ownership: Satisfai Health
Recent Contributions to PracticeUpdate:
- Long-Term Risk of Colorectal Cancer and Related Death After Adenoma Removal
- Colorectal Cancer Risk Factors and Serrated Polyposis Syndrome
- Something’s Left Wanting in Bowel Cleansing Scales
- Impact of Bowel Prep Quality on Adenoma Detection Rate
- Adenoma Recurrence After Wide-Field Endoscopic Mucosal Resection for Advanced Colonic Mucosal Neoplasia Occurs Infrequently
- MY APPROACH to Local Recurrence After EMR of Nonpedunculated Colorectal Lesions
- Ethnicity, Age, and Risk of Large Polyps